List of Tables: Table 11-1: Personal Genome Diagnostics - Liquid Biopsy Associated Product Line Table 11-2: Guardant Health - Liquid Biopsy Associated Product Line Table 11-3: Pathway Genomics - Liquid Biopsy Associated Product Line Table 11-4: RainDance Technologies - Liquid Biopsy Associated Product Line Table 11-5: Trovagene, Inc. - Key Financials (Million US$), 2014-2016 Table 11-6: Trovagene, Inc. - Liquid Biopsy Associated Product Line Table 11-7: Cynvenio Biosystems, Inc. - Liquid Biopsy Associated Product Line Table 11-8: Biocept, Inc. - Key Financials (Million US$), 2014-2016 Table 11-9: Biocept, Inc. - Liquid Biopsy Associated Product Line Table 11-10: ANGLE plc - Key Financials (Million US$), 2014-2016 Table 11-11: ANGLE plc - Liquid Biopsy Associated Product Line Table 11-12: MDxHealth - Key Financials (Million US$), 2014-2016 Table 11-13: MDxHealth - Liquid Biopsy Associated Product Line Table 11-14: Clearbridge BioMedics Pte Ltd - Liquid Biopsy Associated Product Line Table 11-15: Exosome Diagnostics, Inc. - Liquid Biopsy Associated Product Line Table 11-16: Foundation Medicine, Inc. - Key Financials (Million US$), 2014-2016 Table 11-17: Foundation Medicine, Inc. - Liquid Biopsy Associated Product Line Table 11-18: Roche Diagnostics - Net Sales (Million US$), 2014-2016 Table 11-19: Roche Diagnostics - Liquid Biopsy Associated Product Line Table 11-20: Genomic Health - Key Financials (Million US$), 2014-2016 Table 11-21: Genomic Health - Liquid Biopsy Associated Product Line Table 11-22: Myriad Genetics - Key Financials (Million US$), 2014-2016 Table 11-23: Myriad Genetics - Liquid Biopsy Associated Product Line Table 11-24: Thermo Fisher Scientific, Inc. - Net Sales (Million US$), 2014-2016 Table 11-25: Thermo Fisher Scientific, Inc. - Liquid Biopsy Associated Product Line Table 11-26: QIAGEN NV - Net Sales (Million US$), 2014-2016 Table 11-27: QIAGEN NV - Liquid Biopsy Associated Product Line Table 11-28: Bio-Rad Laboratories, Inc. - Key Financials (Million US$), 2014-2016 Table 11-29: Bio-Rad Laboratories, Inc. - Liquid Biopsy Associated Product Line List of Figures: Figure 4-1: Global - Cancer Incidence by Type (Million), 2025 Figure 4-2: Comparison of the analysis capability of CTC’s, cfDNA, and exosomes Figure 5-1: Global - Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 6-1: Major Trends in Commercialized Liquid Biopsy Products Figure 7-1: Global - Liquid Biopsy Market by Technology (%), 2017 Figure 7-2: Global - Liquid Biopsy Market for CTCs (Million US$), 2017 & 2023 Figure 7-3: Global - Liquid Biopsy Market for ctDNA (Million US$), 2017 & 2023 Figure 7-4: Global - Liquid Biopsy Market for Exosomes (Million US$), 2017 & 2023 Figure 8-1: Global - Liquid Biopsy Market by Sample Type (%), 2017 Figure 8-2: Global - Blood Based Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 8-3: Global - Urine Based Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 8-4: Global - Other Fluids Based Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 9-1: Global - Liquid Biopsy Market by Geography (%), 2017 Figure 9-2: North America - Cancer Incidences by Type (‘000), 2015 & 2025 Figure 9-3: North America - Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 9-4: Europe - Cancer Incidences by Type (‘000), 2015 & 2025 Figure 9-5: Europe - Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 9-6: Asia - Cancer Incidences by Type (‘000), 2015 & 2025 Figure 9-7: Asia - Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 9-8: Rest of the World - Liquid Biopsy Market (Million US$), 2017 & 2023 Figure 10-1: Pipeline Analysis for Liquid Biopsy Figure 11-1: Roche Diagnostics - Revenue by Segment (%), 2016 Figure 11-2: Myriad Genetics - Revenue by Segment (%), 2016 Figure 11-3:Thermo Fisher Scientific, Inc. - Revenue by Segment (%), 2016 Figure 11-4: Thermo Fisher Scientific, Inc. - Revenue by Geography (%), 2016 Figure 11-5: QIAGEN NV - Net Sales by Segment (%), 2016 Figure 11-6: QIAGEN NV - Net Sales by Geography (%), 2016

List of Tables: Table 4-1: Global - Cancer Incidence by Type (Million), 2025 Table 4-2: Comparison of the analysis capability of CTC’s, cfDNA, and exosomes Table 6-1: Commercially Developed Liquid Biopsy Kits Table 9-1: North America – Cancer Incidences by Type (‘000), 2015 & 2025 Table 9-2: Europe – Cancer Incidences by Type (‘000), 2015 & 2025 Table 9-3: Asia – Cancer Incidences by Type (‘000), 2015 & 2025 Table 10-1: Pipeline Analysis for Liquid Biopsy Table 11-1: Personal Genome Diagnostics – Liquid Biopsy Associated Product Line Table 11-2: Guardant Health – Liquid Biopsy Associated Product Line Table 11-3: Pathway Genomics – Liquid Biopsy Associated Product Line Table 11-4: NeoGenomics Laboratories, Inc. – Key Financials (Million US$), 2014-2016 Table 11-5: NeoGenomics Laboratories, Inc. – Liquid Biopsy Associated Product Line Table 11-6: Bio-Rad Laboratories, Inc. – Key Financials (Million US$), 2014-2016 Table 11-7: RainDance Technologies – Liquid Biopsy Associated Product Line Table 11-8: Trovagene – Key Financials (Million US$), 2014-2016 Table 11-9: Trovagene – Liquid Biopsy Associated Product Line Table 11-10: Circulogene Theranostics – Liquid Biopsy Associated Product Line Table 11-11: Biocartis Group NV - Key Financials (Million US$), 2014-2016 Table 11-12: Biocartis – Liquid Biopsy Associated Product Line Table 11-13: Cynvenio Biosystems, Inc. – Liquid Biopsy Associated Product Line Table 11-14: Biocept, Inc. - Key Financials (Million US$), 2014-2016 Table 11-15: Biocept, Inc. – Liquid Biopsy Associated Product Line Table 11-16: ANGLE plc - Key Financials (Million US$), FY2015-FY2017 Table 11-17: ANGLE plc – Liquid Biopsy Associated Product Line Table 11-18: MDxHealth - Key Financials (Million US$), 2014-2016 Table 11-19: MDxHealth – Liquid Biopsy Associated Product Line Table 11-20: Clearbridge BioMedics Pte Ltd – Liquid Biopsy Associated Product Line Table 11-21: Exosome Diagnostics, Inc. – Liquid Biopsy Associated Product Line Table 11-22: Foundation Medicine, Inc. - Key Financials (Million US$), 2014-2016 Table 11-23: Foundation Medicine, Inc. – Liquid Biopsy Associated Product Line Table 11-24: Roche Diagnostics - Net Sales (Million US$), 2014-2016 Table 11-25: Roche Diagnostics - Liquid Biopsy Associated Product Line Table 11-26: Genomic Health - Key Financials (Million US$), 2014-2016 Table 11-27: Genomic Health - Liquid Biopsy Associated Product Line Table 11-28: Myriad Genetics - Key Financials (Million US$), 2014-2016 Table 11-29: Myriad Genetics - Liquid Biopsy Associated Product Line Table 11-30: Thermo Fisher Scientific, Inc. - Net Sales (Million US$), 2014-2016 Table 11-31: Thermo Fisher Scientific, Inc. - Liquid Biopsy Associated Product Line Table 11-32: QIAGEN N.V. - Net Sales (Million US$), 2014-2016 Table 11-33: QIAGEN N.V. – Liquid Biopsy Associated Product Line List of Figures: Figure 5-1: Global – Liquid Biopsy Market (Million US$), 2015, 2017 & 2023 Figure 7-1: Global – Liquid Biopsy Market by Technology (%), 2017 Figure 7-2: Global – Liquid Biopsy Market for CTCs (Million US$), 2015, 2017 & 2023 Figure 7-3: Global – Liquid Biopsy Market for ctDNA (Million US$), 2015, 2017 & 2023 Figure 7-4: Global – Liquid Biopsy Market for Exosomes (Million US$), 2015, 2017 & 2023 Figure 8-1: Global – Liquid Biopsy Market by Sample Type (%), 2017 Figure 8-2: Global – Blood Based Liquid Biopsy Market (Million US$), 2015, 2017 & 2023 Figure 8-3: Global - Urine Based Liquid Biopsy Market (Million US$), 2015, 2017 & 2023 Figure 9-1: Global – Liquid Biopsy Market by Geography (%), 2017 Figure 9-2: North America – Liquid Biopsy Market (Million US$), 2015, 2017 & 2023 Figure 9-3: Europe – Liquid Biopsy Market (Million US$), 2015, 2017 & 2023 Figure 9-4: Asia – Liquid Biopsy Market (Million US$), 2015, 2017 & 2023